about
Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma.SREBP-1 has a prognostic role and contributes to invasion and metastasis in human hepatocellular carcinomaMRC2 expression correlates with TGFβ1 and survival in hepatocellular carcinoma.TIMP-1 activated carcinoma-associated fibroblasts inhibit tumor apoptosis by activating SDF1/CXCR4 signaling in hepatocellular carcinomaBCORL1 is an independent prognostic marker and contributes to cell migration and invasion in human hepatocellular carcinoma.MicroRNA-212 suppresses tumor growth of human hepatocellular carcinoma by targeting FOXA1.Clinical Analysis of Intraperitoneal Lymphangioma.Chromatin assembly factor 1, subunit A (P150) facilitates cell proliferation in human hepatocellular carcinomaBCAT1 promotes tumor cell migration and invasion in hepatocellular carcinoma.Ftx non coding RNA-derived miR-545 promotes cell proliferation by targeting RIG-I in hepatocellular carcinomaMethylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma.Lymphocyte-specific protein 1 inhibits the growth of hepatocellular carcinoma by suppressing ERK1/2 phosphorylationTPX2 as a novel prognostic biomarker for hepatocellular carcinoma.Effects of microRNA-30a on migration, invasion and prognosis of hepatocellular carcinoma.Caveolin-1 is up-regulated by GLI1 and contributes to GLI1-driven EMT in hepatocellular carcinoma.MiR-324-3p promotes tumor growth through targeting DACT1 and activation of Wnt/β-catenin pathway in hepatocellular carcinoma.HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.Hypoxia Accelerates Aggressiveness of Hepatocellular Carcinoma Cells Involving Oxidative Stress, Epithelial-Mesenchymal Transition and Non-Canonical Hedgehog Signaling.Is the regulatory effect of PCAF and sirtuin 7 on phosphoglycerate kinase 1 acetylation a universal mechanism underlying hepatocellular carcinoma progression?P300 Acetyltransferase Mediates Stiffness-Induced Activation of Hepatic Stellate Cells Into Tumor-promoting Myofibroblasts.Tanshinol suppresses cardiac allograft rejection in a murine model.MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma.MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C.MicroRNA-645 represses hepatocellular carcinoma progression by inhibiting SOX30-mediated p53 transcriptional activationResolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMPSHMT1 inhibits the metastasis of HCC by repressing NOX1-mediated ROS productionA novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axisRole of ncRNAs in Hepatocellular Carcinoma.LncRNA RUNX1-IT1 which is downregulated by hypoxia-driven histone deacetylase 3 represses proliferation and cancer stem-like properties in hepatocellular carcinoma cellsLncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis
P50
Q33673983-F8F3B637-D2B2-4762-B0DA-7EF67D97C9EDQ33755503-3760F0D3-B4A9-4788-8F09-BEE07952B70AQ34359058-E1158ED7-5D3A-440F-A73E-0CC58359A559Q35828503-EA7B2D08-4831-40F3-9A13-076D45949B0DQ35924344-48A1CE57-2671-461E-8341-966CC3456318Q35955257-EF7A0883-7734-45A5-A903-B0581546BBC8Q36695905-AC8B8599-265B-42F0-B1CC-E49BD4AD50B6Q37074912-CE08298A-C0E9-4D1A-8D1F-8C5663B37481Q37288407-110A148C-B3F3-45EB-B473-11812DAF1607Q37295342-2E77DD53-593B-4B22-B02F-0F70667EA3A3Q37392871-B8A86347-AFB4-4B38-A34F-05F18BB9E41DQ37664313-981AEC8A-E3E8-4F7C-A9A5-532E310D2F00Q38952531-236CD6DF-FEF5-4662-8216-30CBADA9B0BAQ38982148-3A90050B-1764-45C3-84FD-661644B860DBQ39031505-7C178C47-5BD2-4C13-930A-0ADD46463DEEQ42371572-0EDFCE32-0490-4189-BBE8-83F1645F18AEQ47269736-E4B24B58-B6FD-4E5D-8E93-C356407B2195Q47297243-B357B977-38DC-426B-B0A0-C01978740CE0Q48168764-008067FA-D3AA-4E8F-9519-5FFA8211F1F6Q49896590-B156F278-8566-44D4-B1F2-C55CB56B58B9Q51832494-6381A964-75EB-44D0-AAC0-F0D1DB57983BQ52671363-2EC4409C-13CB-4A56-8981-0F9E9F91642BQ53186136-5377A58D-A50E-4EA4-9BD7-EA4D75A1C6DCQ57480162-8DF54809-DB30-4C1E-81FE-9D0DA33E6004Q64103031-9EEAE0DE-9945-4060-BAB0-D8C2B8B8CB42Q64239542-88BC92EF-CDAA-4C20-AFC0-BE1D5899E71DQ64259982-ED13AB9B-08CC-4DA1-9AF4-FCC9EEAAD732Q64950804-1DBB71F9-9E14-4C76-B78B-4D623D0454DAQ89555490-C86D4DA1-1613-4014-89D1-1C47ADC3C142Q90511531-C0A9A4DA-CE8D-4AFC-8674-B8F9B2DE6D73
P50
description
investigador
@es
researcher
@en
name
Kangsheng Tu
@en
type
label
Kangsheng Tu
@en
prefLabel
Kangsheng Tu
@en
P31
P496
0000-0002-0032-1459